The Atlantic has a review of a book
Mind Fixers: Psychiatry's Troubled Search for the Biology of Mental Illnes, (by Anne Harrington) and it's well worth reading. Let's take some extracts:
It follows that psychiatrists also cannot precisely predict for whom and
under what conditions their treatments will work. That is why
antipsychotic drugs are routinely prescribed to depressed people, for
example, and antidepressants to people with anxiety disorders.
Psychiatry remains an empirical discipline, its practitioners as
dependent on their (and their colleagues’) experience to figure out what
will be effective as Pliny Earle and his colleagues were. Little wonder
that the history of such a field—reliant on the authority of scientific
medicine even in the absence of scientific findings—is a record not
only of promise and setback, but of hubris....
As Harrington ably documents, a series of fiascoes highlighted the
profession’s continued inability to answer Clark Bell’s question. Among
them was the 1973 vote by the American Psychiatric Association declaring
that homosexuality was no longer a mental illness. The obvious
question—how scientific is a discipline that settles so momentous a
problem at the ballot box?—was raised by the usual critics. This time,
insurers and government bureaucrats joined in, wondering, often out
loud, whether psychiatry warranted their confidence, and the money that
went along with it.
The association’s response was to purge its Diagnostic and Statistical Manual of Mental Disorders (DSM) of the Freudian theory that had led it to include homosexuality in the first place. When the third edition of the DSM
came out, in 1980, its authors claimed that they had come up with an
accurate list of mental illnesses: Shedding the preconceptions that had
dominated previous taxonomies, they relied instead on atheoretical
descriptions of symptoms. But as Harrington points out, they did have a
theory—that mental illness was no more or less than a pathology of the
brain. In claiming not to, she argues,
they were being
disingenuous. They believed that biological … markers and causes would
eventually be discovered for all the true mental disorders. They
intended the new descriptive categories to be a prelude to the research
that would discover them.
The DSM-3’s gesture at
science proved sufficient to restore the reputation of the profession,
but those discoveries never followed. Indeed, even as the DSM
(now in its fifth edition) remains the backbone of clinical
psychiatry—and becomes the everyday glossary of our psychic
suffering—knowledge about the biology of the disorders it lists has
proved so elusive that the head of the National Institute of Mental
Health, in 2013, announced that it would be “re-orienting its research away from DSM categories.”
I wonder if this review (and the book), is exaggerating a bit? This part, for example:
The need to dispel widespread public doubt haunts another debacle that Harrington chronicles: the rise of the “chemical imbalance”
theory of mental illness, especially depression. The idea was first
advanced in the early 1950s, after scientists demonstrated the
principles of chemical neurotransmission; it was supported by the
discovery that consciousness-altering drugs such as LSD targeted
serotonin and other neurotransmitters. The idea exploded into public
view in the 1990s with the advent of direct-to-consumer advertising of
prescription drugs, antidepressants in particular. Harrington documents
ad campaigns for Prozac and Zoloft that assured wary customers the new
medications were not simply treating patients’ symptoms by altering
their consciousness, as recreational drugs might. Instead, the
medications were billed as repairing an underlying biological problem.
The
strategy worked brilliantly in the marketplace. But there was a catch.
“Ironically, just as the public was embracing the ‘serotonin imbalance’
theory of depression,” Harrington writes, “researchers were forming a
new consensus” about the idea behind that theory: It was “deeply flawed
and probably outright wrong.” Stymied, drug companies have for now
abandoned attempts to find new treatments for mental illness, continuing
to peddle the old ones with the same claims. And the news has yet to
reach, or at any rate affect, consumers. At last count, more than 12 percent of Americans ages 12 and older were taking antidepressants. The chemical-imbalance theory, like the revamped DSM, may fail as science, but as rhetoric it has turned out to be a wild success.
I would have thought that the "chemical imbalance" theory still has significant, experimental support, even if flawed; but I am not expert, just someone who finds the topic interesting.
No comments:
Post a Comment